Information  X 
Enter a valid email address

Syncona Limited (SYNC)

  Print      Mail a friend

Tuesday 30 July, 2019

Syncona Limited

Result of AGM

RNS Number : 2150H
Syncona Limited
30 July 2019
 

Syncona Limited

Result of Annual General Meeting 

30 July 2019

At the Annual General Meeting of the Company held today, all Resolutions as set out in the 'Notice of the 2019 Annual General Meeting' dated 27 June 2019 sent to shareholders of the Company (the "Notice") were duly passed.

Resolutions 1 to 13 were proposed as ordinary resolutions. Resolution 14 was proposed as a Special Resolution and Resolution 15 was proposed as an Extraordinary Resolution.

Details of the proxy voting results, which should be read alongside the Notice, are noted below:

No

Resolution

For

Against

Abstain

Discretion

1

Receive and consider the Annual Audited Financial Statements of the Company for the year ended 31 March 2019, together with the Reports of the Directors and Auditors thereon

435,492,895

247,369

0

25,774

2

Re-appointment Deloitte LLP (Guernsey Branch) as Auditors

435,511,635

24,433

214,970

15,000

3

Authorise the Directors to determine the remuneration of the Auditors

435,733,447

4,076

2,742

25,774

4

Re-elect Jeremy Tigue as a Director

421,376,075

12,076,117

2,288,072

25,774

5

Elect Melanie Gee as a Director

435,735,679

0

4,586

25,774

6

Re-elect Thomas Henderson as a Director

435,554,836

183,585

1,844

25,774

7

Re-elect Rob Hutchinson as a Director

435,726,044

9,635

4,586

25,774

8

Re-elect Nigel Keen as a Director

435,304,724

430,954

4,586

25,774

9

Re-elect Nick Moss as a Director

435,734,955

724

4,586

25,774

10

Re-elect Gian Piero Reverberi as a Director

435,735,679

0

4,586

25,774

11

Re-elect Ellen Strahlman as a Director

435,735,679

0

4,586

25,774

12

Approve the directors' remuneration report.

435,688,593

49,828

1,844

25,774

13

Authority to allot shares

435,723,353

12,326

4,586

25,774

14

Authorise the Company to purchase its own shares

435,722,250

12,693

2,742

28,354

15

Disapply pre-emption rights

435,720,338

1,987

4,586

39,128

A vote withheld is not a vote in law and has not been counted in the votes for and against a resolution.

In accordance with the Listing Rule 9.6.2, a copy of all the resolutions passed other than resolutions concerning ordinary business have been submitted to the UK Listing Authority via the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM.

The full text of the resolutions can be found in the Notice, which is available on the Company's website at www.synconaltd.com/investors.

[ENDS]

Enquiries

Syncona Ltd

Siobhan Weaver / Annabel Clay

Tel: +44 (0) 20 3981 7940

FTI Consulting

Brett Pollard / Natalie Garland-Collins

Tel: +44 (0) 20 3727 1000

Copies of this press release and other corporate information can be found on the company website at: www.synconaltd.com.

About Syncona:

Syncona is a leading FTSE250 healthcare company focused on investing in and building global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.

We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses.

We take a long-term view, underpinned by a deep pool of capital, and are established leaders in the development of gene and cell therapy. We focus on delivering dramatic efficacy for patients in areas of high unmet need.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
RAGWGUPAMUPBGUU

a d v e r t i s e m e n t